Equity Overview
Price & Market Data
Price: $0.455
Daily Change: +$0.143 / 31.52%
Daily Range: $0.312 - $0.465
Market Cap: $993,283
Daily Volume: 35,795
Performance Metrics
1 Week: -31.52%
1 Month: -8.33%
3 Months: 35.43%
6 Months: -76.03%
1 Year: -88.37%
YTD: -84.42%
Company Details
Employees: 2
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
Avenue Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. The company product candidates include AJ201, which is in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; and intravenous tramadol for the treatment of post-operative acute pain. It also develops BAER-101 for the treatment of epilepsy and panic disorders. The company was incorporated in 2015 and is headquartered in Bay Harbor Islands, Florida. Avenue Therapeutics, Inc. is a subsidiary of Fortress Biotech, Inc.